Haemonetics (HAE) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Haemonetics Corporation  (NYSE: HAE)
 

Haemonetics Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HAE Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 5.65 % 6.57 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) -2.26 % -1.87 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 0.48 % 7.21 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 1.36 % 1.5 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 8.91 % 48.61 % 21.33 % 7.33 %


HAE's Growth Comparisons in I. Quarter 2026




Comparing 5.65% year on year top-line growth in the first quarter 2026, Haemonetics grew on the lower pace than the 6.57% growth in the Medical Equipment & Supplies industry and 8.91% Revenue growth in the Healthcare sector. Slow first quarter sales, in the Medical Equipment & Supplies industry and Healthcare sector, were portrayed in Haemonetics Corporation results which underperformed overall market.

Top-line fell by -2.26% from the fourth quarter. Average annual sales growth for Haemonetics is 8.91%, while S & P 500's average yearly sales increase is 7.33%, including only Businesses with the first quarter 2026 financial results.

HAE Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Apheresis
-
-
MedSurg
-
-
United States
6.37 %
-
Japan
-5.79 %
-
Europe
11.37 %
-
Asia
-
-
Other Country or Region
-
-
Total
5.65 %
-74.55 %


Growth Rates of HAE's Income in the first quarter 2026


HAE Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 6.66 % 11.6 % 4.62 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) - 96.14 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) -32.05 % 13.68 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) 2.29 % 2.92 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change 11.8 % 58.04 % 15.48 % 21.6 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -10.42 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - 19.69 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -70.18 % 16.79 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) -49.94 % -2.7 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 4.13 % 51.42 % 21.42 % 24.37 %

HAE Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) -3 % -12.37 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) - 44.98 % -0.77 % 27.07 %
Y / Y Net Income Change (Q2 TTM) -41.05 % -0.27 % 15.51 % 57.33 %
Sequential Net Income Change (Q2 TTM) -1.05 % -3.32 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth 4.13 % 51.42 % 21.42 % 24.34 %

HAE's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 2.82 % -16.23 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - 15.71 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) -36.7 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 0.98 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 5.58 % 64.36 % 21.42 % 24.37 %



HAE EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 2.86 % -18.05 % -26.26 % 24.37 %
Q / Q EPS Net Growth (Q2 MRQ) - 40.16 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 0.99 % - - 4.93 %
EPS Net 5 Year Avg. Change 5.75 % 51.42 % 21.42 % 24.34 %



Haemonetics managed to grow EPS by 2.86% year on year, in the first quarter 2026 to $0.72, while Medical Equipment & Supplies industry fell by -18.05%, Healthcare sector dropped -26.26%. Slow first quarter 2026 income per share, in Medical Equipment & Supplies industry and Healthcare sector, were portrayed in the Haemonetics Corporation results which underperformed overall market.

the bottom-line fell by -2.26% from the fourth quarter. Average annual income per share growth for Haemonetics is 5.75%, while S & P 500's average yearly income per share increase is 24.34%, including only Businesses with the first quarter 2026 earnings.

HAE Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 225.61 % 63.77 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) -16.63 % -54.09 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 53.95 % 39.68 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 11.82 % 8.02 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change 28.9 % 78.59 % 19.23 % 13.04 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - 29.29 % 23.07 % 13.91 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 110.6 % 4.81 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) -55.23 % -21.5 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) -1.19 % -1.63 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 12.67 % -1.55 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change -2.41 % 61.09 % 26.9 % 13.39 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.